
南美洲和中美洲流感疫苗市场预测至 2028 年 - COVID-19 影响和区域分析 - 按疫苗类型(四价疫苗和三价疫苗)、病毒类型(A 型流感病毒和 B 型流感病毒)、技术(基于鸡蛋和基于细胞)、给药途径(注射和鼻喷雾)和目标群体(婴儿、儿童、成人和老年人)
No. of Pages: 132 | Report Code: BMIRE00026974 | Category: Life Sciences
No. of Pages: 132 | Report Code: BMIRE00026974 | Category: Life Sciences
南部和南部中美洲流感疫苗市场预计将从2022年的4.9754亿美元增长到2028年的7.3635亿美元;预计 2022 年至 2028 年复合年增长率为 6.8%。
政府加大力度支持流感疫苗接种
各个州和国家的管理机构正在通过多项活动和计划支持疫苗接种的推广。到 2022 年,已获得足够的疫苗,覆盖所有有资格通过 NIP 接种政府资助的流感疫苗的风险群体。
以下是支持政府支持流感疫苗的更多实例流感疫苗接种:2021年10月,随着流感季节的临近,省政府鼓励所有纽芬兰和拉布拉多人在2021年接种流感疫苗。从2021年10月25日开始,地区卫生当局(RHA)开始举办免费流感疫苗接种活动诊所。人们还可以通过家庭医生或当地药房接种疫苗。因此,增加政府对促进流感疫苗接种的支持正在推动南方和非洲的发展。中美洲流感疫苗市场。
市场概况
南美洲和南美洲中美洲流感疫苗市场分为巴西、阿根廷和南美洲其他地区。中美洲。预计该地区的流感疫苗市场在预测期内将经历增长机会。由于该地区流感病例增加、该地区各种研究活动激增、健康意识提高以及该地区各国医疗保健支出增加等因素,南美的流感疫苗市场预计将增长。
南部和南部地区。中美洲流感疫苗市场收入及预测至 2028 年(百万美元)
南和南中美洲流感疫苗市场细分
南部和中部地区中美洲流感疫苗市场根据疫苗类型、病毒类型、技术、给药途径、目标群体和国家进行细分。
根据疫苗类型,南部和南部中美洲流感疫苗市场分为四价疫苗和三价疫苗。到 2022 年,四价疫苗细分市场将占据更大的市场份额。
根据病毒类型,南美和南美疫苗将占据更大的市场份额。中美洲流感疫苗市场分为 A 型流感病毒和 B 型流感病毒。2022 年 A 型流感病毒市场占有较大份额。
基于技术,南方和中美洲流感疫苗市场分为鸡蛋疫苗和细胞疫苗。到 2022 年,以鸡蛋为基础的细分市场将占据更大的市场份额。
根据给药途径,南部和南部地区中美洲流感疫苗市场分为注射剂和鼻喷雾剂。到 2022 年,注射细分市场将占据更大的市场份额。
根据目标群体,南部和南部地区中美洲流感疫苗市场分为婴儿、儿童、成人和老年人。到 2022 年,婴儿细分市场将占据最大的市场份额。中美洲流感疫苗市场分为巴西、阿根廷和南美洲其他地区。中美洲。巴西在 2022 年占据市场主导地位。
阿斯利康;葛兰素史克公司;三菱化学集团公司;迈兰公司;赛诺菲; SEQIRUS;和印度血清研究所列兵。有限公司是在南部和南部地区运营的领先公司。中美洲流感疫苗市场。
Strategic insights for South & Central America Influenza Vaccines involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.
Report Attribute | Details |
---|---|
Market size in 2022 | US$ 497.54 Million |
Market Size by 2028 | US$ 736.35 Million |
Global CAGR (2022 - 2028) | 6.8% |
Historical Data | 2020-2021 |
Forecast period | 2023-2028 |
Segments Covered |
By 疫苗类型
|
Regions and Countries Covered | 南美洲和中美洲
|
Market leaders and key company profiles |
The regional scope of South & Central America Influenza Vaccines refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.
The South & Central America Influenza Vaccines Market is valued at US$ 497.54 Million in 2022, it is projected to reach US$ 736.35 Million by 2028.
As per our report South & Central America Influenza Vaccines Market, the market size is valued at US$ 497.54 Million in 2022, projecting it to reach US$ 736.35 Million by 2028. This translates to a CAGR of approximately 6.8% during the forecast period.
The South & Central America Influenza Vaccines Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the South & Central America Influenza Vaccines Market report:
The South & Central America Influenza Vaccines Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The South & Central America Influenza Vaccines Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the South & Central America Influenza Vaccines Market value chain can benefit from the information contained in a comprehensive market report.